1 A rare case of cerebral hemorrhage associated with intra-arterial infusion chemotherapy for advanced sphenoid sinus cancer

2 Targeted gold nanoparticles enable molecular CT imaging of head and neck cancer: An in vivo study.

3 Factors driving frequent attendance at emergency departments for patients with head and neck cancer.

4 Advancing interdisciplinary research in head and neck cancer through a multicenter longitudinal prospective cohort study: The NETherlands QUality of life and BIomedical Cohort (NET-QUBIC) data warehouse and biobank

5 Understanding cognitive and emotional illness representations of South Asian head and neck cancer survivors: a qualitative study.

6 Advances in Functional Imaging in the Assessment of Head and Neck Cancer.

7 Physical and Radiobiological Evaluation of Accelerated Intensity Modulated Radiotherapy for Locally Advanced Head and Neck Cancer and Comparison with Short-Term Clinical Outcomes.

8 Impact of the insurance type of head and neck cancer patients on their hospitalization utilization patterns.

9 Do CO and oxidative stress induce cancer?: a brief study about the evaluation of PON 1, CAT, CA and XO enzyme levels on head and neck cancer patients.

10 Effect of photobiomodulation on the severity of oral mucositis and molecular changes in head and neck cancer patients undergoing radiotherapy: a study protocol for a cost-effectiveness randomized clinical trial.

11 Erratum: Safety standards for invasive procedures in out-patient departments, managing subglottic stenosis in pregnancy, a critical review on follow up of head and neck cancer patients, and a new classification for cochleovestibular malformations (Journal of Laryngology and Otology (2019) 133:5 (355-355) DOI: 10.1017/S0022215119001129)

12 Quality of Care Indicators for Head and Neck Cancers: The Experience of the European Project RARECAREnet.

13 Dosimetric and Monte Carlo verification of jaws-only IMRT plans calculated by the Collapsed Cone Convolution algorithm for head and neck cancers.

14 Resources for dysphagia. Dietary adaptations in head and neck cancer

15 Pacientes afectos de neoplasia de cabeza-cuello con nutrición enteral domiciliaria por sonda Head and neck cancer patients included at home enteral nutrition by tube

16 A Pilot Study to Non-Invasively Track PIK3CA Mutation in Head and Neck Cancer

17 Patients' Perspectives on What Makes a Better Care Experience While Undergoing Treatment for Oropharyngeal Dysphagia Secondary to Head and Neck Cancer.

18 Comparison of Head and Neck Cancer Distribution in Turkish and Syrian Populations.

19 Self-care for head and neck cancer survivors with lymphedema and fibrosis: study protocol for a randomized controlled trial.

20 Effect of True and Sham Acupuncture on Radiation-Induced Xerostomia Among Patients With Head and Neck Cancer: A Randomized Clinical Trial

21 Palliative chemotherapy in head and neck cancer: balancing between beneficial and adverse effects.

22 Welding and the risk of head and neck cancer: the ICARE study.

23 CXCL11-CXCR3 axis mediates tumor lymphatic crosstalk and inflammation induced tumor promoting pathways in head and neck cancers.

24 Auditory function and quality of life in patients receiving cisplatin chemotherapy in head and neck cancer: A case series follow-up study.

25 Quality of life of head and neck cancer patients in urban and regional areas: An Australian perspective

26 Quality of life of patients from rural and urban areas in Poland with head and neck cancer treated with radiotherapy. A study of the influence of selected socio-demographic factors

27 Gefitinib and afatinib show potential efficacy for Fanconi anemia-related head and neck cancer.

28 TP53 mutations in head and neck cancer cells determine the Warburg phenotypic switch creating metabolic vulnerabilities and therapeutic opportunities for stratified therapies.

29 NRF2, p53, and p16: Predictive biomarkers to stratify human papillomavirus associated head and neck cancer patients for de-escalation of cancer therapy

30 Global frequency and distribution of head and neck cancer in pediatrics, a systematic review.

31 Emergency changes in international guidelines on treatment for head and neck cancer patients during the COVID-19 pandemic.

32 A randomized phase 2 study of temsirolimus and cetuximab versus temsirolimus alone in recurrent/metastatic, cetuximab-resistant head and neck cancer: The MAESTRO study.

33 Rapid implementation of an evidence-based remote triaging system for assessment of suspected head and neck cancer referrals and patients on follow up after treatment during the COVID-19 pandemic: A model for international collaboration.

34 CD8+CD73+ T cells in the tumor microenvironment of head and neck cancer patients are linked to diminished T cell infiltration and activation in tumor tissue.

35 HPV-Associated Head and Neck Cancer: Molecular and Nano-Scale Markers for Prognosis and Therapeutic Stratification

36 Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer

37 Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

38 Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients

39 Quality of life of head and neck cancer patients before and after cancer-directed treatment – A longitudinal study

40 Implementation of meta-analysis approach, comparing conventional radiotherapy, and proton beam therapy treating head and neck cancer

41 Quality of life of head and neck cancer patients before and after cancer-directed treatment - A longitudinal study

42 Randomised, double-blind, placebo-controlled trial of oral probiotic Streptococcus salivarius M18 on head and neck cancer patients post-radiotherapy: a pilot study

43 evaluation of oral health status and quality of life of head and neck cancer patients after radiation therapy

44 pharmacokinetics of sublingually delivered fentanyl in head and neck cancer patients treated with curatively aimed chemo or bioradiotherapy

45 profiling the behavior of distinct populations of head and neck cancer stem cells

46 recent advances in chemotherapy for head and neck cancers

47 low-dose vs. high-dose cisplatin: lessons learned from 59 chemoradiotherapy trials in head and neck cancer

48 survival of dental implants in native and grafted bone in irradiated head and neck cancer patients: a retrospective analysis

49 a comparison of psychological well-being and quality of life between spouse and non-spouse caregivers in patients with head and neck cancer: a 6-month follow-up study

50 cisplatin-based chemotherapy versus cetuximab in concurrent chemoradiotherapy for locally advanced head and neck cancer treatment

51 cancer stem cells in head and neck cancer

52 targeting head and neck cancer by vaccination

53 biological impact of superparamagnetic iron oxide nanoparticles for magnetic particle imaging of head and neck cancer cells

54 cetuximab in the treatment of head and neck cancer: preliminary results outside clinical trials

55 the tip of the iceberg: clinical implications of genomic sequencing projects in head and neck cancer

56 epidemiological aspects of head and neck cancers in a population of south east region of iran

57 proteomic study of hpv-positive head and neck cancers: preliminary results

58 the role of hpv in head and neck cancer stem cell formation and tumorigenesis

59 t cell-tumor interaction directs the development of immunotherapies in head and neck cancer

60 anti-tumor immunity in head and neck cancer: understanding the evidence, how tumors escape and immunotherapeutic approaches

61 radiofrequency ablation of sphenopalatine ganglion for head and neck cancer pain management

62 self-image of the patients with head and neck cancer: a mixed method research

63 il-6 inhibition with medi5117 decreases the fraction of head and neck cancer stem cells and prevents tumor recurrence

64 impact and prognostic value of 18f-fluorodeoxyglucose positron emission tomography-computed tomography scan in the evaluation of residual head and neck cancer: single-center experience from pakistan

65 qualidade de vida de pacientes com carcinoma em cabeça e pescoço quality of life of patients with head and neck cancer

66 a review of scientific papers about head and neck cancers

67 Saccharomyces cerevisiae fungemia in a head and neck cancer patient: a case report and review of the literature

68 Salivary DNA Methylation as an Epigenetic Biomarker for Head and Neck Cancer. Part II: A Cancer Risk Meta-Analysis

69 Impact of repeat computerized tomography replans in the radiation therapy of head and neck cancers

70 Prognostic value of PD-1, PD-L1 and PD-L2 deserves attention in head and neck cancer.

71 Exposed Necrotic Bone in a Head and Neck Cancer Patient: Report of a Diagnostic Challenge.

72 Associations between substance use, quality of life, and pain among Veteran survivors of head and neck cancer.

73 Preoperative Neoadjuvant Chemotherapy or Immunotherapy in Head and Neck Cancer: A Systematic Review and Meta-Analysis of Surgical Risk and Pathologic Response.

Keyword Connections

Journals

Research Groups

Bibliographies